The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis.
Yoshifumi TadaNobuyuki OnoRie SuematsuSatoko TashiroYuri SadanagaYukiko TokudaYukihide OnoYoshinobu NakaoAkihito MaruyamaAkihide OhtaSyuichi KoaradaPublished in: BMC musculoskeletal disorders (2016)
Treatment with TCZ or ABT differently affected the balance between Foxp3 and Ror-γt expression in the peripheral blood of patients with RA.